Injective's cryptocurrency, INJ, caught the attention of many investors on April 18 due to an exciting new partnership. The layer 1 blockchain, based on Cosmos, announced a strategic merger with Jambo, a company focusing on Web3 mobile technology. This partnership aims to bring blockchain-based financial solutions to developing regions like Africa, Southeast Asia, and Latin America.

After the announcement of this collaboration, the price of INJ started to rise, sparking optimism in the market. The merger with Jambo means that Injective's native dApps, including Ninji Wallet, will be available on JamboPhones, making it easier for millions of users to access the Injective ecosystem.

Jambo specializes in making affordable, user-friendly mobile technology to connect emerging markets with the digital world. Their latest product, the JamboPhone, runs on Web3 Android 13, and now it will support Injective's DeFi initiatives.

The price of INJ saw a significant increase following the partnership announcement, indicating positive sentiment among investors. Currently, INJ is trading at $28.39, marking a 15.36% gain in the past 24 hours. The token's market cap and trading volume also experienced notable growth, reflecting a bullish trend.

Data from Coinglass revealed a substantial rise in INJ's open interest and derivatives volume, further reinforcing the positive outlook for Injective. Investors are excited about the potential for a post-halving rally in the token's price.

In conclusion, Injective's collaboration with Jambo has led to a surge in the price of the INJ token. This partnership opens up new opportunities for Injective in emerging markets, and investors are optimistic about its future growth.